Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines

Cancer Research

Volumn 59, Issue 11, 1999, Pages 2657-2667

  Giacomini, Patrizio ^a   Giorda, Ezio ^a   Fraioli, Rocco ^a   Nicotra, Maria Rita ^a,b   Vitale, Nello ^a   Setini, Andrea ^a   Delfino, Laura ^c   Morabito, Anna ^c   Benevolo, Maria ^a   Venturo, Irene ^a   Mottolese, Marcella ^a   Ferrara, Giovan Battista ^c   Natali, Pier Giorgio ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; COLON CARCINOMA; ENDOMETRIUM CANCER; FLOW CYTOMETRY; HLA TYPING; HUMAN; HUMAN CELL; LUNG CANCER; MELANOMA; MOLECULAR RECOGNITION; OVARY CANCER; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; DOWN-REGULATION; EPITOPES; FLOW CYTOMETRY; GENOTYPE; HLA-A ANTIGENS; HLA-B ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC SURVEILLANCE; NEOPLASMS; POLYMORPHISM, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033152198     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Bodmer, W. F. HLA: what's in a name? A commentary on HLA nomenclature development over the years. Tissue Antigens, 49: 293-296, 1997.
2. Pamer, E., and Cresswell, P. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol., 16: 323-358, 1998.
3. Lanier, L. L. NK cell receptors. Annu. Rev. Immunol., 16: 359-393, 1998.
4. 2m: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and IFN-γ responsiveness. Tissue Antigens, 50: 555-566, 1997.
5. Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., and Stern, P. L. Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol. Today, 18: 89-95, 1997.
6. Boon, T., and Old, L. J. Cancer tumor antigens. Curr. Opin. Immunol., 9: 681-683, 1997.
7. Ferrone, S., and Marincola, F. M. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol. Today, 16: 487-494, 1995.
8. Natali, P. G., Nicotra, M. R., Bigotti, A., Venturo, I., Marcenaro, L., Giacomini, P., and Russo, C. Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc. Natl. Acad. Sci. USA, 86: 6719-6723, 1989.
9. Kaklamanis, L., Leek, R., Koukourakis, M., Gatter, K. C., and Harris, A. L. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res., 55: 5191-5194, 1995.
10. Korkolopoulou, P., Kaklamanis, L., Pezzella, F., Harris, A. L., and Gatter, K. C. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br. J. Cancer, 73: 148-153, 1996.
11. Smith, M. E. F., Bodmer, W. F., and Bodmer, J. G. Selective loss of HLA-A, B, C locus products in colorectal adenocarcinoma. Lancet, Vol. 1, 823-824, 1988.
12. 2-microglobulin mRNA in human colon carcinoma. J. Exp. Med., 169: 309-314, 1989.
13. Smith, M. E., Marsh, S. G., Bodmer, J. G., Gelsthorpe, K., and Bodmer, W. F. Loss of HLA-A, B, C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc. Natl. Acad. Sci. USA, 86: 5557-5561, 1989.
14. 2-microglobulin in colorectal cancer. Int. J. Cancer, 51: 379-385, 1992.
15. Garrido, F., Cabrera, T., Accolla, R. S., Bensa, J. C., Bodmer, W., Dohr, G., Drouet, M., Fauchet, R., Ferrara, G. B., Ferrone, S., Giacomini, P., Kageshita, T., Koopman, L., Maio, M., Marincola, M., Mazzilli, C., Morel, P. A., Murray, A., Papasteriades, C. R. H., Salvaneschi, L., Stern, P. L., and Ziegler, A. HLA and cancer: 12th International Histocompatibility Workshop study. In: D. Charron (ed.), Genetic Diversity of HLA. Functional and Medical Implication, pp. 445-452. Sevres, France: EDK, 1997.
16. Cabrera, T., Angustias Fernandez, M., Sierra, A., Garrido, A., Herruzo, A., Escobedo, A., Fabra, A., and Garrido, F. High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum. Immunol., 50: 127-134, 1996.
17. Houghton, A. N., Eisinger, M., Albino, A. P., Cairncross, J. G., and Old, L. J. Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets. J. Exp. Med., 156: 1755-1766, 1982.
18. Taramelli, D., Fossati, G., Mazzocchi, A., Delia, D., Ferrone, S., and Parmiani, G. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. Cancer Res., 46: 433-439, 1986.
19. Giacomini, P., Fraioli, R., Nisticò, P., Tecce, R., Nicotra, M. R., Di Filippo, F., Fisher, P. B., and Natali, P. G. Modulation of the antigenic phenotype of early-passage human melanoma cells derived from multiple autologous metastases by recombinant human leukocyte, fibroblast and immune interferon. Int. J. Cancer, 46: 539-545, 1990.
20. Versteeg, R., Noordermeer, I. A., Kruse-Wolters, M., Ruiter, D. J., and Schrier, P. I. c-myc down-regulates class I HLA expression in human melanomas. EMBO J., 7: 1023-1029, 1988.
21. Wang, P., Vanky, F., and Klein, E. Application of isoeleclric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas. Cancer Immunol. Immunother., 33: 65-69, 1991.
22. Vegh, Z., Wang, P., Vanky, F., and Klein, E. Selectively down-regulated expression of major histocompatibility complex class I alleles in human solid tumors. Cancer Res., 53: 2416-2420, 1993.
23. Versteeg, R., Kruse-Wolters, K. M., Plomp, A. C., van Leeuwen, A., Stam, N. J., Ploegh, H. L., Ruiter, D. J., and Schrier, P. I. Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. J. Exp. Med., 170: 621-635, 1989.
24. 2-m in metastatic melanomas from five patients receiving immunotherapy. J. Natl. Cancer Inst., 88: 100-108, 1996.
25. Marincola, F. M., Shamamian, P., Alexander, R. B., Gnarra, J. R., Turetskaya, R. L., Nedospasov, S. A., Simonis, T. B., Taubenberger, J. K., Yannelli, J., Mixon, A., Restifo, N. P., Herlyn, M., and Rosenberg, S. A. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines. J. Immunol., 153: 1225-1237, 1994.
26. Parham, P., Androlewicz, M. J., Brodsky, F. M., Holmes, N. J., and Ways, J. P. Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens. J. Immunol. Methods, 53: 133-173, 1982.
27. Giacomini, P., Mottolese, M., Fraioli, R., Benevolo, M., Venturo, I., and Natali, P. G. Antigenic modulation of metastatic breast and ovary carcinoma cells by intracavitary injection of IFN-α. Br. J. Cancer, 66: 342-344, 1992.
28. Giacomini, P., Segatto, O., and Natali, P. G. Multiple epitope recognition: an approach to improved radioimmunodetection of tumor associated antigens. Int. J. Cancer, 39: 729-736, 1987.
29. 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens. Eur. J. Immunol., 9: 536-545, 1979.
30. Pellegrino, M A., Ng, A. K., Russo, C., and Ferrone, S. Heterogenous distribution of determinants defined by monoclonal antibodies on HLA-A, -B antigen bearing molecules. Transplantation, 34: 18-23, 1982.
31. Parham, P., Barnstable, C. J., and Bodmer, W. F. Use of monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens. J. Immunol., 23: 342-349, 1979.
32. Slam, N. J., Spits, H., and Ploegh, H. L. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C products. J. Immunol., 137: 2299-2306, 1986.
33. Lozano, F., Santos-Aguado, J., Borche, L., Places, L., Domenech, N., Gaya, A., Vilella, R., and Vives, J. Identification of the amino acid residues defining an intralocus determinant in the α1 domain of HLA-A molecules. Immunogenetics, 30: 50-53, 1989.
34. Spear, B. T., Kornbluth, J., Strominger, J. L., and Wilson, D. B. Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131. J. Exp. Med., 162: 1802-1810, 1985.
35. Quaranta, V., Pellegrino, M. A., and Ferrone, S. The monoclonal xenoantibody Q6/64 recognizes a determinant expressed by certain gene products of the A and B loci of the HLA region. Immunogenetics, 14: 403-413, 1981.
36. Parham, P., and Bodmer, W. F. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2. Nature (Lond.), 276: 397-399, 1978.
37. Russo, C., Ng, A. K., Pellegrino, M. A., and Ferrone, S. The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics, 18: 23-35, 1983.
38. Parham, P., and Brodsky, F. M. Partial purification and some properties of BB7.2. A cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA A28. Hum. Immunol., 3: 277-299, 1981.
39. Brodsky, F. M., Parham, P., Barnstable, C. J., Crumpton, M. J., and Bodmer, W. F. Monoclonal antibodies for analysis of the HLA system. Immunol. Rev., 47: 3-61, 1979.
40. Pera, C., Delfino, L., Morabito, A., Longo, A., Johnston-Dow, L., White, C. B., Colonna, M., and Ferrara, G. B. HLA-A typing: comparison between serology, the amplification refractory mutation system with polymerase chain reaction and sequencing. Tissue Antigens, 50: 372-379, 1997.
41. McCutcheon, J. A., Gumperz, J., Smith, K. D., Lutz, C. T., and Parham, P. Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J. Exp. Med., 181: 2085-2095, 1995.
42. Christinck, E. R., Luscher, M. A., Barber, B. H., and Williams, D. B. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature (Lond.), 352: 67-70, 1991.
43. Rivoltini, L., Barracchini, K. C., Viggiano, V., Kawakami, Y., Smith, A., Mixon, A., Restifo, N. P., Topalian, S. L., Simonis, T. B., and Rosenberg, S. A. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes. Cancer Res., 55: 3149-3157, 1997.